LTGO
Latigo Biotherapeutics, Inc.
16.60$
+4.6%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
Latigo Biotherapeutics, Inc. (LTGO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -21 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|
| -21 | -22 | -27 | -21 | |
| 0.1 | 0.1 | 0.0 | 0.1 | |
| 1.5 | 1.7 | 2.0 | 2.1 | |
| -1.8 | 1.5 | -6.3 | 1.9 | |
| 0.1 | 0.0 | 0.0 | 0.0 | |
| 99 | 0.0 | -0.2 | 34 | |
| 78 | -22 | -27 | 13 | |
| -21 | -22 | -27 | -21 |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.